These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 11384207

  • 1. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
    Pineau N, Lelievre V, Goursaud S, Hilairet S, Waschek JA, Janet T, Muller JM.
    Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
    [Abstract] [Full Text] [Related]

  • 2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 3. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T.
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [Abstract] [Full Text] [Related]

  • 4. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Pol J Pharmacol; 2004 Jan; 56(2):203-11. PubMed ID: 15156071
    [Abstract] [Full Text] [Related]

  • 5. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 6. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
    [Abstract] [Full Text] [Related]

  • 7. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG, Rodriguez-Henche N, García-López E, Noguerales F, Dapena MA, Juarranz MG, Prieto JC.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [Abstract] [Full Text] [Related]

  • 8. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [Abstract] [Full Text] [Related]

  • 9. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Aug; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 10. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
    Diehl NL, Kermode JC, Shreeve SM.
    Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
    [Abstract] [Full Text] [Related]

  • 11. Expression and GTP sensitivity of peptide histidine isoleucine high-affinity-binding sites in rat.
    Debaigt C, Meunier AC, Goursaud S, Montoni A, Pineau N, Couvineau A, Laburthe M, Muller JM, Janet T.
    Ann N Y Acad Sci; 2006 Jul; 1070():215-9. PubMed ID: 16888169
    [Abstract] [Full Text] [Related]

  • 12. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R, Montoni A, Bulteau-Pignoux L, Janet T, Moreau B, Muller JM, Becq F.
    Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
    [Abstract] [Full Text] [Related]

  • 13. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R, Prieto JC, Guerrero JM, Goberna R.
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [Abstract] [Full Text] [Related]

  • 14. Structural characterization of PACAP receptors on rat liver plasma membranes.
    Nguyen TD, Heintz GG, Wolfe MS.
    Am J Physiol; 1993 Nov; 265(5 Pt 1):G811-8. PubMed ID: 8238511
    [Abstract] [Full Text] [Related]

  • 15. VIP activates G(s) and G(i3) in rat alveolar macrophages and G(s) in HEK293 cells transfected with the human VPAC(1) receptor.
    Shreeve SM, Sreedharan SP, Hacker MP, Gannon DE, Morgan MJ.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):922-8. PubMed ID: 10860852
    [Abstract] [Full Text] [Related]

  • 16. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug 16; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 17. Investigation and characterization of receptors for pituitary adenylate cyclase-activating polypeptide in human brain by radioligand binding and chemical cross-linking.
    Suda K, Smith DM, Ghatei MA, Murphy JK, Bloom SR.
    J Clin Endocrinol Metab; 1991 May 16; 72(5):958-64. PubMed ID: 1673686
    [Abstract] [Full Text] [Related]

  • 18. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T, Ito S, Ohta T, Asano T, Nakazato Y.
    Biochem Pharmacol; 1994 Jan 20; 47(2):241-5. PubMed ID: 8304967
    [Abstract] [Full Text] [Related]

  • 19. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L.
    J Endocrinol; 2008 Feb 20; 196(2):291-303. PubMed ID: 18252952
    [Abstract] [Full Text] [Related]

  • 20. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M.
    Regul Pept; 2004 Aug 15; 120(1-3):99-105. PubMed ID: 15177926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.